
Jiangsu gdk Biotechnology Co., Ltd.
SSE:688670.SS
13.52 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||
Net Income
| -93.503 | -70.99 | 41.544 | 82.46 | 154.979 | -19.038 | -28.013 | -32.662 |
Depreciation & Amortization
| 30.419 | 29.873 | 29.759 | 28.076 | 25.807 | 23.297 | 21.068 | 18.624 |
Deferred Income Tax
| 0 | -15.584 | 3.777 | -14.648 | 49.956 | -12.209 | -13.35 | 0 |
Stock Based Compensation
| 0 | 0 | 0.757 | 0.729 | 14.99 | 0 | 0 | 0 |
Change In Working Capital
| -62.619 | 102.78 | -61.26 | -70.315 | -112.267 | -57.635 | -14.228 | -11.542 |
Accounts Receivables
| -13.816 | 241.606 | -7.189 | 13.373 | -307.643 | -62.515 | -0.179 | 0 |
Inventory
| -32.851 | -44.834 | -39.031 | -48.915 | -14.827 | -15.536 | -1.825 | -0.104 |
Accounts Payables
| 0 | -93.992 | -18.817 | -20.126 | 160.247 | 32.625 | 1.126 | 0 |
Other Working Capital
| -15.952 | -0 | 3.777 | -14.648 | 49.956 | -12.209 | -12.403 | -11.438 |
Other Non Cash Items
| -5.685 | 34.826 | 24.018 | 77.623 | -24.01 | -0.672 | -14.306 | -7.659 |
Operating Cash Flow
| -131.387 | 80.905 | 38.595 | 103.925 | 109.456 | -54.048 | -35.478 | -33.238 |
Investing Activities: | ||||||||
Investments In Property Plant And Equipment
| -38.477 | -54.004 | -168.178 | -386.389 | -40.809 | -21.123 | -6.22 | -33.886 |
Acquisitions Net
| 0 | 0 | 0 | 0.05 | 0.015 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | -615 | -0.015 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 11.624 | 11.297 | 15.874 | 4.946 | 0.405 | 0.086 | 0.068 | 0.329 |
Other Investing Activites
| 173.445 | -145 | 265 | 0 | -30.855 | -3.38 | 5.54 | -11.29 |
Investing Cash Flow
| 146.593 | -187.708 | 112.696 | -996.392 | -71.259 | -24.418 | -0.611 | -44.847 |
Financing Activities: | ||||||||
Debt Repayment
| -16.4 | 0 | 0 | -286.35 | -134.5 | 26.8 | 0 | 30 |
Common Stock Issued
| 0 | 0 | 0 | -13.124 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 13.124 | 0 | 0 | 0 | 0 |
Dividends Paid
| -1.626 | -17.6 | -44 | -9.855 | -8.439 | -3.157 | -4.565 | -2.234 |
Other Financing Activities
| 0 | 20.118 | 32 | 1,140.613 | 185.205 | 58.7 | 44.1 | 50 |
Financing Cash Flow
| -18.026 | 2.518 | -13.25 | 841.139 | 42.266 | 82.343 | 39.535 | 77.766 |
Other Information: | ||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0.002 | -0 | 0 | 0 | -0 | 0 |
Net Change In Cash
| -2.82 | -104.285 | 138.043 | -51.328 | 80.462 | 3.877 | 3.445 | -0.319 |
Cash At End Of Period
| 67.623 | 70.444 | 174.729 | 36.686 | 88.014 | 7.552 | 3.675 | 0.23 |